Status:
COMPLETED
RayGel-An Alternative for Skin Care During External Beam Radiation
Lead Sponsor:
Nathalie Johnson
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
This study is for the patient with breast cancer. To take part in this study, external beam radiation therapy needs to be part of the treatment plan. Reduced glutathione, an ingredient of RayGel™, has...
Detailed Description
RayGel versus Placebo- An Alternative for Skin Care during External Beam Radiation Therapy RayGel is a formulation of reduced glutathione and anthocyanins extracts from various blue/purple flowering ...
Eligibility Criteria
Inclusion
- 1\. Breast Cancer
- Radiation
Exclusion
- Post Mastectomy
- Previous irradiation of the same breast
- Pregnacy
- Younger than 18 years of age
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00266331
Start Date
October 1 2004
End Date
May 1 2011
Last Update
August 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Legacy Health System
Portland, Oregon, United States, 97210